Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

H Yoshihara

Showing results (141-150 of 154) with videos related to

Pageof 16
Sort By:
Journal of Gastroenterology and Hepatology|October 12, 2001
Significance of serum soluble Fas antigen level in chronic hepatitis C patients treated with interferon: relationship to the therapeutic responseK Ohkawa, N Hiramatsu, K Mochizuki, et al.
Nihon Shokakibyo Gakkai Zasshi = the Japanese Journal of Gastro-Enterology|March 1, 1983
[Evaluation of alcoholic liver diseases by multiple regression analysis of the results of liver function tests]A Kasahara, N Hayashi, N Sato, et al.
Gastrointestinal Endoscopy|February 1, 1997
Disease stage of chronic hepatitis C assessed by both peritoneoscopic and histologic findings and its relationship with response to interferon therapyK Ohkawa, N Hayashi, N Yuki, et al.
Journal of Viral Hepatitis|June 26, 2001
Immunological response to interferon-gamma priming prior to interferon-alpha treatment in refractory chronic hepatitis C in relation to viral clearanceK Katayama, A Kasahara, Y Sasaki, et al.
International Journal of Cancer|August 5, 2000
Effect of interferon therapy on the incidence of hepatocellular carcinoma and mortality of patients with chronic hepatitis C: a retrospective cohort study of 738 patientsH Tanaka, H Tsukuma, A Kasahara, et al.
Hepatology (Baltimore, Md.)|October 2, 1998
Gene expression of alpha1-6 fucosyltransferase in human hepatoma tissues: a possible implication for increased fucosylation of alpha-fetoproteinK Noda, E Miyoshi, N Uozumi, et al.
Nihon Gan Chiryo Gakkai Shi|August 20, 1981
[Protective effect of L-cysteine on the leukopenic syndrome due to radiotherapy (author's transl)]K Jingu, K Matsuura, Y Bussaka, et al.
Journal of Hepatology|March 1, 1997
Circulating matrix metalloproteinase-2 and tissue inhibitor of metalloproteinase-1 as serum markers of fibrosis in patients with chronic hepatitis C. Relationship to interferon responseA Kasahara, N Hayashi, K Mochizuki, et al.
Cancer Research|July 1, 1996
Expression of vascular permeability factor/vascular endothelial growth factor in human hepatocellular carcinomaK Suzuki, N Hayashi, Y Miyamoto, et al.
Journal of Viral Hepatitis|August 2, 2014
The real impact of telaprevir dosage on the antiviral and side effects of telaprevir, pegylated interferon and ribavirin therapy for chronic hepatitis C patients with HCV genotype 1T Oze, N Hiramatsu, T Yakushijin, et al.
Pageof 16

Showing results (141-150 of 154) with videos related to

Sort By:
Pageof 16
Journal of Gastroenterology and Hepatology|October 12, 2001
Significance of serum soluble Fas antigen level in chronic hepatitis C patients treated with interferon: relationship to the therapeutic responseK Ohkawa, N Hiramatsu, K Mochizuki, et al.
Nihon Shokakibyo Gakkai Zasshi = the Japanese Journal of Gastro-Enterology|March 1, 1983
[Evaluation of alcoholic liver diseases by multiple regression analysis of the results of liver function tests]A Kasahara, N Hayashi, N Sato, et al.
Gastrointestinal Endoscopy|February 1, 1997
Disease stage of chronic hepatitis C assessed by both peritoneoscopic and histologic findings and its relationship with response to interferon therapyK Ohkawa, N Hayashi, N Yuki, et al.
Journal of Viral Hepatitis|June 26, 2001
Immunological response to interferon-gamma priming prior to interferon-alpha treatment in refractory chronic hepatitis C in relation to viral clearanceK Katayama, A Kasahara, Y Sasaki, et al.
International Journal of Cancer|August 5, 2000
Effect of interferon therapy on the incidence of hepatocellular carcinoma and mortality of patients with chronic hepatitis C: a retrospective cohort study of 738 patientsH Tanaka, H Tsukuma, A Kasahara, et al.
Hepatology (Baltimore, Md.)|October 2, 1998
Gene expression of alpha1-6 fucosyltransferase in human hepatoma tissues: a possible implication for increased fucosylation of alpha-fetoproteinK Noda, E Miyoshi, N Uozumi, et al.
Nihon Gan Chiryo Gakkai Shi|August 20, 1981
[Protective effect of L-cysteine on the leukopenic syndrome due to radiotherapy (author's transl)]K Jingu, K Matsuura, Y Bussaka, et al.
Journal of Hepatology|March 1, 1997
Circulating matrix metalloproteinase-2 and tissue inhibitor of metalloproteinase-1 as serum markers of fibrosis in patients with chronic hepatitis C. Relationship to interferon responseA Kasahara, N Hayashi, K Mochizuki, et al.
Cancer Research|July 1, 1996
Expression of vascular permeability factor/vascular endothelial growth factor in human hepatocellular carcinomaK Suzuki, N Hayashi, Y Miyamoto, et al.
Journal of Viral Hepatitis|August 2, 2014
The real impact of telaprevir dosage on the antiviral and side effects of telaprevir, pegylated interferon and ribavirin therapy for chronic hepatitis C patients with HCV genotype 1T Oze, N Hiramatsu, T Yakushijin, et al.
Pageof 16